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Abstract
Objective:  To  evaluate  the  presence  of  insulin  resistance  and  its  association  with  other
metabolic abnormalities  in  obese  children  and  adolescents.
Methods:  Retrospective  study  of  220  children  and  adolescents  aged  5-14  years.  Anthropometric
measurements were  performed  (weight,  height,  and  waist  circumference)  and  clinical  (gender,
age,  pubertal  stage,  and  degree  of  obesity)  and  biochemical  (glucose,  insulin,  total  choles-
terol,  and  fractions,  triglycerides)  data  were  analyzed.  Insulin  resistance  was  identiﬁed  by  the
homeostasis  model  assessment  for  insulin  resistance  (HOMA-IR)  index.  The  analysis  of  the  dif-
ferences  between  the  variables  of  interest  and  the  HOMA-IR  quartiles  was  performed  by  ANOVA
or  Kruskal-Wallis  tests.
Results: Insulin  resistance  was  diagnosed  in  33.20%  of  the  sample.  It  was  associated  with  low
levels  of  high-density  lipoprotein  cholesterol  (HDL-C;  p  =  0.044),  waist  circumference  measure-
ment  (p  =  0.030),  and  the  set  of  clinical  and  metabolic  (p  =  0.000)  alterations.  Insulin-resistant
individuals had  higher  mean  age  (p  =  0.000),  body  mass  index  (BMI;  p  =  0.000),  abdominal
circumference (p  =  0.000),  median  triglycerides  (p  =  0.001),  total  cholesterol  (p  ≤  0.042),  and
low-density  lipoprotein  cholesterol  (LDL--C;  p  ≤  0.027);  and  lower  HDL-C  levels  (p  =  0.005).
There  was  an  increase  in  mean  BMI  (p  =  0.000),  abdominal  circumference  (p  =  0.000),  and  median
triglycerides  (p  =  0.002)  as  the  values  of  HOMA  -IR  increased,  with  the  exception  of  HDL-C,  which
decreased  (p  =  0.001).  Those  with  the  highest  number  of  simultaneous  alterations  were  between
the  second  and  third  quartiles  of  the  HOMA--IR  index  (p  =  0.000).
 Please cite this article as: Romualdo MC, de Nóbrega FJ, Escrivão MA. Insulin resistance in obese children and adolescents. J Pediatr (Rio
). 2014;90:600--7.
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Conclusion:  The  results  conﬁrmed  that  insulin  resistance  is  present  in  many  obese  children  and
adolescents,  and  that  this  condition  is  associated  with  alterations  that  represent  an  increased
risk  for  developing  metabolic  disorders  in  adulthood.
©  2014  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Resumo
Objetivo:  Avaliar  a  presenc¸a de  resistência  à  insulina  e  sua  relac¸ão  com  outras  alterac¸ões
metabólicas, em  crianc¸as  e  adolescentes  obesos.
Métodos:  Estudo  retrospectivo  de  220  crianc¸as  e  adolescentes  de  5  a  14  anos.  Foram  real-
izadas avaliac¸ões  antropométricas  (peso,  estatura  e  circunferência  abdominal),  clínicas  (sexo,
idade,  estágio  puberal  e  grau  de  obesidade)  e  bioquímicas  (glicemia,  insulina,  colesterol  total  e
frac¸ões,  triglicerídeos).  A  resistência  à  insulina  foi  identiﬁcada  pelo  índice  HOMA-IR.  A  análise
das  diferenc¸as  entre  as  variáveis  de  interesse  e  os  quartis  do  HOMA-IR  foi  realizada  pelos  testes
ANOVA  ou  Kruskal-Wallis.
Resultados:  A  resistência  à  insulina  foi  diagnosticada  em  33,20%  da  amostra.  Associou-se  a
níveis baixos  de  HDL-C  (p  =  0,044),  medida  da  circunferência  abdominal  aumentada  (p  =  0,030)
e  ao  conjunto  de  alterac¸ões  clínicas  e  metabólicas  (p  =  0,000).  Os  indivíduos  resistentes  apresen-
taram  maiores  médias  de  idade  (p  =  0,000),  IMC  (p  =  0,000),  medida  da  circunferência  abdominal
(p  =  0,000)  e  maiores  medianas  de  triglicerídeos  (p  =  0,001),  colesterol  total  (p  ≤  0,042),  LDL-
C  (p  ≤  0,027)  e  menores  de  HDL-C  (p  =  0,005).  Houve  aumento  das  médias  de  IMC  (p  =  0,000),
medida  da  circunferência  abdominal  (p  =  0,000)  e  mediana  de  triglicerídeos  (p  =  0,002)  à  medida
que  os  valores  do  HOMA-IR  se  elevavam,  com  excec¸ão  dos  níveis  de  HDL-C  que  diminuíram
(p =  0,001).  Aqueles  que  apresentaram  o  maior  conjunto  de  alterac¸ões  simultâneas  estavam
entre  o  segundo  e  terceiro  quartis  do  HOMA-IR  (p  =  0,000).
Conclusão: Os  resultados  conﬁrmaram  que  a  resistência  à  insulina  está  presente  em  muitas
crianc¸as e  em  muitos  adolescentes  obesos,  e  que  esta  condic¸ão  está  associada  a  alterac¸ões  que
representam  aumento  do  risco  para  o  desenvolvimento  de  distúrbios  metabólicos  na  maturi-
dade.
©  2014  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  
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Obesity  is  a  chronic  disease  with  multifactorial  etiology.
Its occurrence  is  associated  with  increased  morbidity  and
mortality and  reduced  life  expectancy.  In  childhood  and  ado-
lescence, it  often  leads  to  important  metabolic  alterations,
which, depending  on  the  duration  and  severity,  may  deter-
mine the  development  of  chronic  diseases  in  adulthood.1,2
In  this  context,  insulin  resistance  (IR)  is  emerging  as  an
important disorder  among  young  individuals.  Studies  have
emphasized that  patients  with  IR  have  a  higher  predisposi-
tion to  the  future  development  of  metabolic  syndrome  (MS),
type II  diabetes  mellitus  (DM2),  and  cardiovascular  disease.
Correlations were  identiﬁed  between  IR  and  clinical  and
metabolic alterations,  especially  among  obese  children  and
adolescents, indicating  that  obesity  is  a  major  trigger  for
their development.3--7
The  mechanisms  by  which  IR  occurs  are  not  entirely  clear.
It is  essentially  characterized  by  the  decrease  in  the  capacity
of attaining  normal  plasma  insulin  concentrations,  promot-
ing adequate  peripheral  glucose  uptake,  maintaining  liver
glycogenesis in  balance,  and  inhibiting  the  production  of
very-low-density lipoprotein.8 The  diagnosis  of  IR  is  not  easy,
a
p
aue  to  the  lack  of  a  single  method  capable  of  estimating  the
egree of  individual  sensitivity  to  insulin.
Among  the  different  methods  are  the  direct  tests,  which
eek to  analyze  the  effects  of  a  predetermined  amount
f administered  insulin  (insulin  tolerance  test,  insulin  sup-
ression test,  and  clamping),  and  the  indirect  tests,  which
valuate the  effect  of  endogenous  insulin  (fasting  insulin,
omeostasis model  assessment  [HOMA],  and  the  oral  glucose
olerance test  [OGTT]).  The  gold  standard  is  the  hyperin-
ulinemic euglycemic  clamp  method,  but  the  complexity
nd high  cost  of  the  method  prevent  its  use  in  daily  clini-
al practice  and  in  epidemiological  studies.9 The  HOMA  for
nsulin resistance  (HOMA-IR)  index  is  a  widely  used  method
n adults  and  has  been  validated  in  children  and  adoles-
ents, by  comparing  with  rates  based  on  the  OGTT  and  the
yperinsulinemic euglycemic  clamp.
Some  authors  recommend  that  cutoff  values  of  approxi-
ately 3  are  able  to  identify  IR  in  this  population.10--15 IR  is
ne of  the  most  important  effects  found  in  obese  patients
nd it  appears  to  be  the  factor  that  triggers  other  metabolic
lterations. Thus,  the  present  study  aimed  to  evaluate  the
resence of  IR  and  its  associations  with  other  metabolic
bnormalities in  obese  children  and  adolescents.
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ple (mean  value  of  HOMA-IR  index  =  3.26  ±  2.67).  The  highest02  
ethods
his  was  a  retrospective  cross-sectional  study,  with  primary
ata collection  performed  in  children  and  adolescents  from
he Obesity  Outpatient  Clinic  in  Osasco,  São  Paulo,  from
pril of  2010  to  January  of  2012.  A  total  of  220  patients  were
nalyzed, aged  5  to  14  years  old,  who  had  not  undergone  any
eight reduction  intervention.  The  minimum  sample  size
201 children  and  adolescents)  was  calculated  taking  into
ccount the  outcome  of  IR  in  this  population,  a  signiﬁcance
evel of  5%  (  =  0.05),  statistical  power  of  95%  (1  -    =  0.95),
nd 20%  eventual  losses.
Measurements  of  weight,  height,  and  waist  circumfer-
nce (WC)  were  obtained  at  the  anthropometric  assessment.
eight was  measured  using  a  platform-type  Filizola  scale
Filizola, São  Paulo,  Brazil)  placed  on  a  smooth  surface,  with
apacity up  to  150  kg  and  precision  of  100  g.  The  subjects
ere barefoot  and  wearing  light  clothing,  standing  on  the
enter of  the  scale  and  in  vertical  position.  Height  was  mea-
ured in  the  standing  position,  barefoot  and  heels  in  parallel,
sing a  stadiometer  with  a  resolution  of  1  mm.  To  evaluate
he nutritional  status  of  children  and  adolescents,  the  body
ass index  (BMI)  Z-score  was  used,  according  to  the  criteria
roposed by  the  World  Health  Organization,16 and  individ-
als were  categorized  as  obese  (BMI  z  >  +  2  ≤  +  3)  or  severely
bese (BMI  z  >  +  3).
WC  was  measured  with  the  individual  in  the  standing
osition, at  midpoint  between  the  lower  border  of  the
ast rib  and  the  upper  border  of  the  iliac  crest  on  the
orizontal plane,  using  an  inextensible  tape  graduated  in
illimeters. WC  was  considered  to  be  increased  when  its
alue was  at  or  above  the  90th percentile  for  gender  and
ge.17
The  degree  of  sexual  maturity  of  individuals  was  assessed
y a  pediatric  endocrinologist  and  classiﬁed  according  to
anner.18 Therefore,  individuals  were  considered  prepuber-
al when  they  were  at  stage  1l  pubertal  at  stages  2,  3,  and
; and  post-pubertal  at  stage  5.  Laboratory  tests  were  per-
ormed according  to  the  routine  of  the  Obesity  Outpatient
linic and  included  serum  total  cholesterol  and  fractions,
riglycerides, insulin,  and  fasting  glucose  levels.
Blood  samples  were  collected  by  venipuncture  after
asting for  12  hours.  The  samples  were  collected  in  vac-
um tubes  containing  separator  gel,  without  anticoagulant.
fter collection,  the  blood  was  centrifuged  for  ten  min-
tes at  3,000  rpm  to  separate  the  serum  from  the  remaining
omponents, and  the  serum  was  then  used  to  perform
he analyses.  The  levels  of  total  cholesterol,  triglyce-
ides, high-density  lipoprotein  cholesterol  (HDL-C),  and
lucose were  determined  using  enzymatic  colorimetric  kits
rocessed in  an  Autohumalyzer  A5  (Human  GMBH,  Kaiser-
lautern, Germany).  Insulin  was  measured  in  an  ACS-180
utomated Chemiluminescense  System  (Ciba  Corning,  Diag-
ostics Corp.,  Mediﬁeld,  USA),  and  low-density  lipoprotein
holesterol (LDL-C)  was  calculated  using  the  equation  of
riedewald et  al.19
The  results  were  compared  with  reference  values  for  chil-
ren and  adolescents  of  the  I  Guideline  for  Prevention  of
therosclerosis in  Childhood  and  Adolescence.20 The  HOMA-
R index  was  used  to  evaluate  IR  and  obtained  by  calculating
he product  of  fasting  plasma  insulin  (U/mL)  and  fasting
lasma glucose  (mmol/L)  divided  by  22.5.  The  cutoff  used
f
a
bRomualdo  MC  et  al.
as  greater  than  or  equal  to  3.43  for  both  genders,  accord-
ng to  Garcia  Cuartero  et  al.15
The  following  were  considered  clinical  and  metabolic
bnormalities: fasting  glucose  ≥  100  mg/dL,  fasting  insulin
 15  microU/mL,  total  cholesterol  ≥  170  mg/dL,  LDL-C  ≥
30 mg/dL,  HDL-C  ≤  45  mg/dL,  triglycerides  ≥  130  mg/dL,
nd waist  circumference  ≥  90th  percentile.  A  set  of  clini-
al and  metabolic  alterations  was  deﬁned  for  each  individual
ccording to  the  number  of  prevalent  conditions  that  ranged
rom 0  (no  alteration)  to  7  (presence  of  all  alterations).  The
roject was  approved  by  the  Research  Ethics  Committee
f Universidade  Federal  de  São  Paulo  - UNIFESP.  Data  col-
ection was  performed  after  written  informed  consent  was
btained from  the  institution  where  the  study  was  carried
ut. Data  were  entered  into  Excel  2010  (Microsoft,  Washing-
on, USA)  spreadsheets  and  analyzed  using  SPSS  version  19.0
IBM Company,  New  York,  USA).  Continuous  variables  were
ested for  normality  of  distribution  by  Kolmogorov-Smirnov
est. The  differences  for  these  variables  were  analyzed  using
he  Mann-Whitney  U-test  or  Student’s  t-test,  according  to
he distribution.  Categorical  variables  were  compared  by
hi-squared test  (with  correction  by  Fisher’s  exact  test).  To
valuate IR  and  its  association  with  clinical  and  metabolic
ariables, the  HOMA-IR  index  was  distributed  into  quartiles
nd the  differences  between  the  values  of  these  varia-
les were  evaluated  by  ANOVA  or  the  Kruskal-Wallis  test,
ccording to  the  distribution.  For  all  analyses,  statistical
igniﬁcance was  considered  as  p  <  0.05.
esults
 total  of  220  obese  children  and  adolescents  (50%  girls,
4.1% children,  46.4%  severely  obese,  and  51.8%  prepu-
ertal individuals)  with  a  mean  age  of  9.13  ±  2.11  years
ere included  in  the  study.  Signiﬁcant  percentages  of  clin-
cal and  metabolic  alterations  were  found:  increased  WC
easurements (89.5%),  hyperinsulinemia  (42.3%),  hypercho-
esterolemia (35%),  elevated  LDL-C  (23%),  and  low  HDL-C
55.9%). Fasting  glucose  alteration  was  observed  in  one  child
nd in  eight  adolescents.  Table  1  presents  the  absolute
alues and  percentages  of  clinical  and  metabolic  char-
cteristics of  the  children  and  adolescents.  The  highest
requencies of  post-pubertal  individuals  (18.2%  vs.  2.7%
 = 0.005),  alterations  in  fasting  insulin  (52.7%  vs.  31.8%
 = 0.002),  and  IR  (41.8%  vs.  24.5%  p  =  0.007)  were  observed
mong females.  Fasting  glucose  was  abnormal  in  3.6%  of
ales and  4.5%  of  females,  although  there  was  no  signiﬁcant
ifference between  genders  (p  =  0.500).
Males and  females  were  similar  regarding  age  (p  =  0.052),
egree of  obesity  (p  =  0.058),  WC  increase  (p  =  0.076),  and
lterations in  levels  of  total  cholesterol  (p  =  0.079),  LDL-C
p =  0.417),  HDL-C  (p  =  0.208),  and  triglycerides  (p  =  0.436).
t was  found  that  15.5%  of  the  males  and  16.4%  of  the
emales had  four  clinical  or  metabolic  alterations  simul-
aneously, although  no  difference  was  observed  between
enders (p  =  0.991).  IR  was  diagnosed  in  33.20%  of  the  sam-requencies of  IR  were  observed  among  adolescents  (65.8%)
nd pubertal  subjects  (54.8%).  There  were  associations
etween IR  and  low  levels  of  HDL-C  (p  =  0.044),  increased
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Table  1  Absolute  and  percentage  values  of  clinical  and  metabolic  characteristics  of  obese  children  and  adolescents,  according
to  gender  and  HOMA-IR  index.
Gender  pa HOMA-IR  index  pa
Variables  Male
n  (%)
Female
n  (%)
HOMA  ≤  3.43  HOMA  ≥  3.43
Age  range
Child  (5  to  9  years)  53  (48.2)  66  (60)  0.052  94  (63.9)  25  (34.2)  0.000
Adolescent (10  to  14  years)  57  (51.8)  44  (40)  25  (34.2)  48  (65.8)
Pubertal stage
Prepubertal  67  (60.9)  47  (42.7)  0.005  91  (61.9)  23  (31.5)  0.000
Pubertal 40  (36.4)  43  (39.1)  54  (36.7)  40  (54.8)
Post-pubertal 3  (2.7)  20  (18.2)  2  (1.4)  10  (13.7)
Degree of  obesity
Obesity 52  (47.3)  66  (60)  0.058  81  (55.1)  37  (50.7)  0.536
Severe obesity  58  (52.7)  44  (40)  66  (44.9)  36  (49.3)
Glycemia ≥  100mg/dL  4  (3.6)  5  (4.5)  0.500  --  --
Insulin ≥  15  U/mL  35  (31.8)  58  (52.7)  0.002  --  --
TC ≥  170  mg/dL  44  (40)  33  (30)  0.079  53  (72.6)  20  (27.4)  0.101
LDL-C ≥  130  mg/dL  12  (10.9)  14  (12.7)  0.417  64  (87.7)  9  (12.3)  0.869
HDL-C ≤  45  mg/dL  58  (52.7)  65  (59.1)  0.208  25  (34.2)  48  (65.8)  0.044
Triglycerides ≥  130  mg/dL  26  (23.6)  24  (21.8)  0.436  51  (69.9)  22  (30.1)  0.087
Increased WC  103  (93.6)  94  (85.5)  0.076  8  (11.0)  65  (89)  0.030
IR 27  (24.5)  46  (41.8)  0.007  --  --
Clinical and  metabolic  alterations
0 2  (1.8)  2  (1.8)  0.991  0  (0)  0.000
1 19  (17.3)  17  (15.5)  2  (2.7)
2 40  (36.4)  36  (32.7)  14  (19.2)
3 23  (20.9)  27  (24.5)  25  (34.2)
4 17  (15.5)  18  (16.4)  22  (30.1)
5 8  (7.3)  9  (8.2)  9  (12.3)
6 1  (0.9)  1(0.9)  1  (1.4)
HOMA-IR, homeostasis model assessment for insulin resistance; TC, total cholesterol; LDL-C, low-density lipoprotein-cholesterol; HDL-C,
high-density lipoprotein-cholesterol; WC, waist circumference; IR, insulin resistance.
o
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la Chi-squared test with correction through Fisher’s exact test.
WC  measurement  (p  =  0.030),  and  the  number  of  clinical  and
metabolic alterations  (p  =  0.000)  (Table  1).
Table 2  demonstrates  that  the  insulin  resistant  individ-
uals had  higher  mean  age  (9.97  ±  1.88  versus  8.71  ±  2.10,
p =  0.000),  BMI  (27.67  ±  3.14  versus  25.18  ±  p  =  0.000),
WC measurement  (90  ±  10.04  cm  versus  81.82  ±  8.87  cm  p
= 0.000)  and  higher  median  triglyceride  levels  (85  mg/dL
(30-246 mg/dL)  versus  106  mg/dL  (41-293  mg/dL)  p  =  0.001)
when compared  with  those  who  did  not  have  IR.  Excep-
tions were  observed  in  relation  to  median  total  cholesterol
(153.35 ±  32.64  mg/dL  versus  162.70  ±  29.99  mg/dL,  p  ≤
0.042); LDL-C  (87.40  mg/dL  (24.20-175.60  mg/dL)  versus
98 mg/dL  (29.20-167  mg/dL),  p  ≤  0.027);  and  HDL-C
(41 mg/dL  (26-67  mg/dL)  versus  44  mg/dL  (28-83  mg/dL),
p =  0.005),  which  decreased  in  the  presence  of  IR.  In  the
distribution of  clinical  and  metabolic  variables  of  children
and adolescents  according  to  HOMA-IR  quartiles,  increases
in mean  BMI  (p  =  0.000),  WC  measurement  (p  =  0.000),  and
median triglycerides  (p  =  0.002)  were  also  observed  as  the
values of  HOMA-IR  increased,  except  for  HDL-C,  which
decreased (p  =  0.001).
a
w
c
tThere were  no  signiﬁcant  differences  between  the  values
f total  cholesterol  (p  =  0.242)  and  the  LDL-C  and  the  HOMA-
R quartiles  (p  =  0.444;  Table  3).  Those  with  the  highest
umber of  simultaneous  clinical  and  metabolic  alterations
ere between  the  second  and  third  quartiles  of  the  HOMA-IR
ndex (p  =  0.000)  (Fig.  1).
iscussion
hildhood  can  be  considered  a  critical  period  for  the
nset or  continuity  of  obesity,  and  the  starting  point
or the  emergence  and  development  of  important  clinical
nd metabolic  changes,  which,  depending  on  the  dura-
ion and  severity,  can  impair  the  health  in  adulthood.21
hen  assessing  the  nutritional  status  of  children  and  ado-
escents, it  is  important  not  only  to  know  the  chronological
ge, but  also  the  degree  of  sexual  maturity,  especially
hen assessing  the  risk  of  persistence  of  obesity  and  asso-
iated morbidities,  as  the  probability  of  a obese  child
o remain  obese  as  an  adult  ranges  from  20%  to  50%
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Table  2  Central  tendency  and  dispersion  values  of  the  clinical  and  metabolic  variables  tendency  of  children  and  adolescents,
according  to  the  absence  or  presence  of  insulin  resistance.
Insulin  resistance
Absent  Present  p
Variables
Age  (years)  8.71  ±  2.10  9.97  ±  1.88  0.000a
BMI  (kg/m2)  25.18  ±  3.14  27.67  ±  3.35  0.000a
WC  (cm)  81.82  ±  8.87  90.00  ±  10.04  0.000a
TC  (mg/dL)  161  (97-244)  149  (82.6-250)  0.042b
LDL-C  (mg/dL)  98  (29.20-167)  87.40  (24.20-175.60)  0.027b
HDL-C  (mg/dL)  44  (28-83)  41  (26-67)  0.005b
Triglycerides  (mg/dL) 85  (30-246) 106  (41-293) 0.001b
BMI, body mass index; WC, waist circumference; TC, total cholesterol; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density
lipoprotein-cholesterol.
a Student’s t-test: values expressed as mean (SD).
b Mann-Whitney test: values expressed as median (Vmin − Vmax).
Table  3  Clinical  and  metabolic  proﬁle  of  obese  children  and  adolescents,  according  to  quartiles  of  the  HOMA-IR  index.
HOMA-IR
Variables  ≤  1.49  1.50  --  2,64  2.65  --  4.23  ≥  4.24  p
BMI  (Kg/m2)  24.01  ±  2.62  25.33  ±  2.60  26.30  ±  3.39  28.35  ±  3,42  0.000a
WC  (cm) 77.50  ±  8.10  83.34  ±  7.54  85.43  ±  8.76  91.85  ±  10.06  0.000a
TC  (mg/dL) 160  (99-244) 158  (97-232)  163  (83-235)  149  (82.6-250)  0.242b
LDL-C  (mg/dL) 94.40  (43.6-145) 98  (29.2-167) 93.80  (42-151.8)  87.80  (24.2-175.6)  0.444b
HDL-C  (mg/dL) 47  (31-83) 46  (28-66)  43  (26-84)  41  (26-67)  0.001b
Triglycerides  (mg/dL) 77  (30-232)  86  (45-214)  93  (47-246)  106  (41-293)  0.002b
HOMA-IR, homeostasis model assessment for insulin resistance; BMI, body mass index; WC, waist circumference; TC, total cholesterol;
popro
.
p
p
a
a
F
o
N
≥LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density li
a ANOVA test: values expressed as mean (SD).
b Kruskal-Wallis test: values expressed as median (Vmin − Vmax)
rior  to  sexual  maturation  and  from  50%  to  70%  after
uberty.22
The  present  study  showed  that  42.7%  of  individuals  had
lready started  puberty,  and  that  most  of  these  children  and
a
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dolescents,  in  addition  to  obesity,  had  important  clinical
nd metabolic  alterations,  similar  to  those  found  in  other
tudies that  showed  that  increased  BMI  potentiates  the  onset
f metabolic  risk  factors  in  this  population.  The  ﬁnding  of
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tInsulin  resistance  in  obese  children  and  adolescents  
nine  cases  of  impaired  fasting  glucose  (one  case  among  the
children and  eight  cases  among  the  adolescents)  is  an  object
of concern  due  to  its  early  onset,  as  this  alteration  is  rarely
seen in  children  and  adolescents,  even  in  samples  consisting
only of  obese  individuals.
The prevalence  of  alterations  in  fasting  insulin,  and  HDL-
C and  LDL-C  lipid  fractions  are  relevant,  as  studies  have
shown that  hyperinsulinemia  is  an  independent  risk  factor
for the  development  of  cardiovascular  disease,  by  potenti-
ating the  onset  of  dyslipidemia.  In  this  situation,  there  is
a decrease  in  the  capacity  of  insulin  to  stimulate  glucose
utilization by  muscle  and  adipose  tissue,  causing  damage  to
lipolysis suppression,  a  condition  that  increases  the  circula-
tion of  free  fatty  acids  and  further  alters  glucose  transport
to target  tissues,  inhibiting  insulin  action.  Insulin  resis-
tance leads  to  increased  fatty  acid  oxidation,  providing
substrate for  the  synthesis  of  triglycerides  and  increasing
LDL-C release  to  serum.23,24 A  study  that  evaluated  the  levels
of serum  insulin  for  eight  years  in  children  aged  5-9  years  and
young adults  aged  17-23  years  demonstrated  that,  among
those with  hyperinsulinemia,  dyslipidemia  cases  were  three-
fold higher.25
Serrano  et  al.  observed  that  overweight  adolescents  were
4.5-fold more  likely  to  have  alterations  in  HOMA-IR  index
and that  these  values  were  higher  in  adolescents  with
higher percentage  of  body  fat.26 Costa  et  al.  investigated
the clustering  of  cardiovascular  risk  factors  in  118  chil-
dren and  adolescents  according  to  BMI  quartiles  and  found
that being  overweight  was  associated  with  increased  blood
pressure, triglycerides,  HOMA-IR  index,  and  low  HDL-C,  com-
prising  a  pro-atherosclerotic  proﬁle  in  this  population.27 In
the present  study,  the  identiﬁed  prevalence  of  IR  is  con-
sistent with  that  found  by  other  authors  in  national  and
international studies,  which  conﬁrms  the  severity  of  the
problem.4,6,7 This  condition  was  associated  with  female  gen-
der, adolescents,  pubertal  individuals,  decrease  in  serum
HDL-C, increased  waist  circumference,  and  the  number  of
clinical and  metabolic  alterations  found  in  the  group.
The  literature  demonstrates  that  there  is  still  no  consen-
sus on  the  cutoff  of  HOMA-IR  for  the  assessment  of  children
and adolescents,  as  these  values  tend  to  vary  during  these
life stages.  To  establish  a  correlation  between  the  cutoff  and
the associated  risk,  it  is  necessary  to  develop  prospective
studies that  would  consider,  among  other  things,  that  the
values of  fasting  insulin  vary  during  childhood  and  adoles-
cence, which  demand  a  long  period  of  observation.  However,
there is  an  agreement  that  research  on  the  association
between obesity  and  IR  in  children  and  adolescents  may  pro-
mote the  early  identiﬁcation  of  factors  that  inﬂuence  the
development of  cardiovascular  disease  and  DM2.11--15
In  this  study,  to  adjust  for  the  physiological  IR  that  occurs
during adolescence,  it  was  decided  to  use  the  HOMA-IR
cutoff of  3.43  suggested  by  Garcia  Cuartero  et  al.,15 who
assessed children  and  adolescents  aged  1  month  to  18  years
by taking  into  account  variations  of  this  index  for  age  and
gender, also  noting  the  pubertal  stage  according  to  the  Tan-
ner criteria.18
In  the  present  study,  when  evaluating  the  values  of  the
clinical and  metabolic  variables  of  these  children  and  ado-
lescents according  to  the  presence  or  absence  of  IR,  it  was
observed that  those  who  were  insulin-resistant  had  higher
values of  BMI,  WC,  and  triglycerides,  and  decreased  HDL-C
a
t
t
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evels,  in  agreement  with  other  studies  that  also  highlighted
he association  between  obesity,  IR,  and  metabolic  alter-
tions in  children  and  adolescents.
Mieldazis  et  al.,  when  investigating  the  association
etween BMI,  HOMA-IR,  and  insulin  levels  in  a  group  of
re-pubertal children,  concluded  that  there  is  a  strong  asso-
iation between  hyperinsulinemia  and  obesity,  and  that  the
igher the  BMI,  the  higher  the  HOMA-IR  index.3 Madeira
t al.,  when  assessing  the  impact  of  obesity  on  the  com-
onents of  metabolic  syndrome  (MS)  in  children,  found  that
bese children  showed  differences  in  mean  HDL-C,  HOMA-IR,
erum insulin,  glucose/insulin  ratio,  and  waist  circumfer-
nce, demonstrating  that  obesity  had  a  signiﬁcant  inﬂuence
n the  metabolism.13
Lavrador  et  al.  observed  that  in  a  sample  of  80  post-
ubertal obese  adolescents  divided  into  lower  and  higher
egrees of  obesity,  those  with  a higher  degree  of  obesity  had
igher frequencies  of  alterations  in  blood  glucose,  HOMA-
R, triglycerides,  HDL-C,  and  blood  pressure,  demonstrating
hat the  degree  of  obesity  inﬂuences  the  onset  of  clinical  and
etabolic alterations,28 differently  from  the  present  study,
n which  no  signiﬁcant  differences  were  found  between  the
egree of  obesity  by  gender  and  presence  of  insulin  resis-
ance. The  method  of  distributing  the  sample  according  to
he quartiles  of  the  HOMA-IR  index  of  the  assessed  children
nd adolescents  conﬁrmed  that  the  higher  the  values  of
OMA-IR, the  higher  the  values  of  BMI,  WC  measurement,
nd triglycerides,  and  the  lower  the  values  of  HDL-C,  in
greement with  other  studies  such  as  that  of  Ferreira  et  al.,
hich evaluated  the  association  of  BMI  and  IR  with  MS  in
razilian children.  The  MS  identiﬁed  in  the  obese  individ-
als and  many  of  the  risk  factors  that  comprise  it  were
bove the  third  quartile  of  the  HOMA-IR  index.  These  ﬁnd-
ngs reinforce  the  likely  participation  of  obesity  and  IR  in
he development  of  cardiovascular  risk  factors,  as  these
ere higher  in  the  higher  percentiles  of  BMI  and  HOMA-IR.7
n  a  case-control  study  that  evaluated  the  association  of
isk factors  for  cardiovascular  disease  in  52  children  with
R, it  was  observed  that  the  obese  children  had  a  higher
revalence of  MS.  Those  with  higher  IR  had  more  metabolic
isk factors,  and  MS  was  present  in  17.3%  of  the  assessed
hildren. In  the  same  study,  the  mean  HOMA-IR  index  was
igniﬁcantly different  for  females  (3.8  ±  2.2,  95%  CI:  2.9-
.8) when  compared  to  males  (2.6  ±  1.3,  95%  CI:  2.1-3.1),
 =  0.016.6
In  the  present  study,  the  frequency  of  simultaneous
ccurrence of  clinical  and  metabolic  alterations  was  more
ften observed  between  the  second  and  third  quartiles.
owever, the  mean  values  of  HOMA-IR  in  this  study  were
igher than  those  found  by  Medeiros  et  al.5 (2.4),  Fer-
eira et  al.6 (3.2),  Weiss  et  al.29 (3.12  to  8.69,  according
o the  degree  of  obesity),  and  Hirschler  et  al.30 (2.76),  dif-
erences that  may  be  in  part  explained  by  obesity.  Other
actors that  were  not  addressed  in  the  present  study,  such
s time  of  exposure  to  obesity  and  eating  habits,  can  strongly
ontribute to  IR.  Although  there  is  no  consensus  on  the  diag-
osis of  IR  in  children  and  adolescents,  it  is  recommended
hat isolated  or  combined  clinical  and  metabolic  alterations
re monitored  especially  in  obese  individuals,  considering
hat excess  body  fat  is  the  most  important  risk  factor  for
he development  of  non-communicable  chronic  diseases  in
dulthood.
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In  fact,  the  present  study  conﬁrms  the  literature  data
y showing  that  IR  is  present  in  obese  children  and  adoles-
ents, and  that  this  condition  is  associated  with  clinical  and
etabolic alterations.  Despite  the  limitations  inherent  to
ll cross-sectional  studies  regarding  the  difﬁculty  in  deﬁning
he temporal  sequence  of  the  line  of  causality,  the  present
ndings contribute  to  a  better  understanding  of  the  associa-
ion between  IR  and  metabolic  effects  frequently  observed
n obese  children  and  adolescents.  It  is  noteworthy  that  the
bserved association  between  IR  and  the  variables  analyzed
n this  study  indicate  an  increased  risk  for  the  development
f cardiovascular  disease,  DM2,  and  MS  in  adulthood  for  this
roup.
The monitoring  of  this  population,  with  periodic  reassess-
ents of  the  analyzed  parameters,  can  provide  greater
onsistency to  the  results.  Obesity  is  a  chronic  disease
ith important  consequences  that  tend  to  worsen  with
verweight persistence  and  severity.  Therefore,  treatment
hould be  carried  out  adequately,  by  a  multidisciplinary
eam and  always  with  the  inclusion  of  the  family.  Possi-
le targets  should  be  set  according  to  the  reality  of  each
atient, aiming  at  achieving  a  progressive  reduction  in  BMI
nd maintenance  of  the  results  achieved  in  relation  to  nutri-
ional status  and  improvement  of  clinical  and  metabolic
lterations.
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